Skip to content

Effect of transdermal hormone therapy combined with ARB in hypertensive postmenopausal women

Effect of transdermal hormone therapy combined with ARB in hypertensive postmenopausal women - Combination therapy with transdermal HT and ARB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007815
Enrollment
60
Registered
2012-04-24
Start date
2012-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, climacteric disorder

Interventions

ARB ARB + HRT HRT

Sponsors

Aichi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Postmenopausal women with climacteric symptoms

Exclusion criteria

Exclusion criteria: Women contraindicated of HRT

Design outcomes

Primary

MeasureTime frame
Blood pressure

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026